Immunity Pharma Israeli Company
Immunity Pharma (IPL) develops therapies for neurodegenerative diseases with an initial focus on amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
Health Tech & Life Sciences
Alternatives
No alternatives listed yet.
Suggest an Alternative
Office Locations
Jerusalem, Israel